UPDATE 2-'Impressed' FDA panel unanimously recommends GSK shingles vaccine
September 13, 2017 at 15:49 PM EDT
Sept 13 (Reuters) - A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline's Shingrix shingles vaccine warrants approval for its use in adults aged 50 and over.